JEFFREY HOFFSOMMER: Open Payments
NPI 1598765026 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 19 payments from 10 companies in 2025. Trend: 2023 $394 · 2024 $380 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $71 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Exact Sciences Corporation | 4 | $62 |
| Lilly USA, LLC | 2 | $33 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| Gilead Sciences, Inc. | 1 | $16 |
| Dexcom, Inc. | 1 | $15 |
| ABBVIE INC. | 1 | $14 |
Products named: REXULTI, Cologuard Collection Kit, AIRSUPRA, MOUNJARO, FANAPT, AUSTEDO XR, TRUMENBA, BREZTRI.
Industry payments across OK — which companies pay providers there.
